EUVIMEDEUVIMED entdecken
Open Access

Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotype

Sanshiro Kobayashi, Naoyuki Kondo, Takashi Tomiyama, Naohiro Nakamura, Masataka Masuda, Yasushi Matsumoto, Yusuke Honzawa, Tomomitsu Tahara, Tsukasa Ikeura, Toshiro Fukui, Kazuichi Okazaki, Makoto Naganuma

Cancer Immunology, Immunotherapy · 2023

DOI: 10.1007/s00262-023-03517-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2023. Verfasst von Sanshiro Kobayashi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka, 573-…. Hauptthemen laut MEDLINE: Colonic Neoplasms, Adenocarcinoma, Lung Neoplasms, Extracellular Vesicles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Grant-in-Aid for Young Scientists JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) of the Ministry of Culture and Science of Japan, Research Program from the Japan Medical Research and Development (AMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Colorectal cancer is a disease of unmet medical need. Although extracellular vesicles (EVs) have been implicated in anti-tumor responses, discrepancies were observed among studies. We analyzed the role of tumor-derived EVs (TEVs) in tumor progression in vivo by focusing on regulatory T (Treg) cells, which play essential roles in tumor development and progression. METHODS: A mouse model of colorectal cancer lung metastasis was generated using BALB/c mice by tail vein injection of the BALB/c colon adenocarcinoma cell line Colon-26. TEVs derived from Colon-26 and BALB/c lung squamous cell carcinoma ASB-XIV were retrieved from the culture media supernatants. A TEV equivalent to 10 µg protein was injected every other day for 2 weeks. RESULTS: Histology and immunohistochemistry studies revealed that lung tumors reduced in the Colon-26-EV group when compared to the phosphate-buffered saline (PBS) group. The population of CD4 + FoxP3 + cells in the lung was upregulated in the PBS group mice when compared to the healthy mice (P < 0.001), but was significantly downregulated in the Colon-26-EV group mice when compared to the PBS group mice (P < 0.01). Programmed cell death protein 1, glucocorticoid-induced TNFR-related protein, and CD69 expression in lung Treg cells were markedly upregulated in the PBS group when compared to the healthy mice, but downregulated in the Colon-26-EV group when compared to the PBS group. The changes in expression were dose-dependent for Colon-26-EVs. ASB-EVs also led to significantly downregulated Treg cell expression, although non-cancer line 3T3-derived EVs did not. CONCLUSION: Our study suggests that TEVs possess components for tumor suppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsAdenocarcinomaLung NeoplasmsExtracellular VesiclesMiceAnimalsT-Lymphocytes, RegulatoryInjections, IntravenousCell Line, TumorPhenotype

Stichwörter der Autor:innen

Colorectal cancerExtracellular vesicleRegulatory T cellTumor progressionTumor-derived extracellular vesicles

Autor:innen und Institutionen

  • Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka, 573-1010, Japan.
  • Department of Molecular Genetics, Institute of Biomedical Science, Kansai Medical University, Hirakata, Osaka, 573-1010, Japan.
  • Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka, 573-1010, Japan. tomiyata@hirakata.kmu.ac.jp.

Förderung

  • Grant-in-Aid for Young Scientists JSPS KAKENHI
  • Grant-in-Aid for Scientific Research (C) of the Ministry of Culture and Science of Japan
  • Research Program from the Japan Medical Research and Development (AMED)
  • Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan
  • Research Program on Intractable Diseases, from the Ministry of Labor and Welfare of Japan
  • Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan

Zitieren

APA

Kobayashi, S., Kondo, N., Tomiyama, T., Nakamura, N., Masuda, M., Matsumoto, Y., Honzawa, Y., Tahara, T., Ikeura, T., Fukui, T., Okazaki, K., & Naganuma, M. (2023). Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotype. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-023-03517-0

Vancouver

Kobayashi S, Kondo N, Tomiyama T, Nakamura N, Masuda M, Matsumoto Y, et al. Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotype. Cancer Immunology, Immunotherapy. 2023. doi:10.1007/s00262-023-03517-0

BibTeX
@article{Kobayashi2023,
  author = {Kobayashi, Sanshiro and Kondo, Naoyuki and Tomiyama, Takashi and Nakamura, Naohiro and Masuda, Masataka and Matsumoto, Yasushi and Honzawa, Yusuke and Tahara, Tomomitsu and Ikeura, Tsukasa and Fukui, Toshiro and Okazaki, Kazuichi and Naganuma, Makoto},
  title = {Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotype},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2023},
  doi = {10.1007/s00262-023-03517-0}
}
Kostenlos starten →